A 58-year-old man with newly diagnosed type 2 diabetes has no established cardiovascular disease, no chronic kidney disease, and no significant comorbidities. His HbA1c is 8.2% despite 3 months of lifestyle modification. According to Diabetes Canada pharmacologic guidelines, what is the preferred initial pharmacologic therapy?